NTAGI panel recommends inclusion of Covovax in vaccination drive for 12-17 age group

NTAGI panel recommends inclusion of Covovax in vaccination drive for 12-17 age group

The Standing Technical Sub-Committee of the NTAGI has recommended inclusion of the Serum Institute’s Covovax in the national COVID-19 vaccination programme for children aged 12 to 17 years, sources said on Friday. India’s drug regulator had approved Covovax for restricted use in emergency situations in adults on December 28 last year and in the 12-17 … Read more

UK expands COVID vaccines to at-risk 5 to 11-year-old kids

UK expands COVID vaccines to at-risk 5 to 11-year-old kids

The UK‘s National Health Service (NHS) on Sunday expanded its COVID-19 vaccination programme to cover vulnerable children aged five to 11 years. Eligible children include those with diabetes, immunosuppression, learning disabilities, and other serious conditions that place them at a high risk from COVID-19. NHS England said nearly 500,000 eligible children in England are set … Read more